Table 2.
Comparison of clinical characteristics of patients with a final diagnosis of PNF or DGF
| Characteristics | PNF (n = 15) | DGF (n = 17) | p value |
|---|---|---|---|
| Age, mean ± SD, years | 56±14 | 46±21 | 0.10 |
| Gender – male, n (%) | 8 (53) | 9 (53) | 0.98 |
| No. of prior kidney transplants, mean ± SD | 1.3±0.5 | 1.4±0.7 | 0.72 |
| Dialysis duration, mean ± SD, months | 62±40 | 63±64 | 0.97 |
| Weight, mean ± SD, kg | 77±11 | 68±22 | 0.22 |
| Height, mean ± SD, m | 1.62±9 | 1.64±9 | 0.54 |
| BMI, mean ± SD, kg/m2 | 30±6 | 26±5 | 0.06 |
|
| |||
| Graft | |||
| Cold ischemia time, mean ± SD, h | 11±5 | 10±8 | 0.69 |
| Cadaveric graft, n (%) | 12 (80) | 10 (59) | 0.20 |
| Donor gender – male, n (%) | 4 (27) | 9 (53) | 0.13 |
| Donor age, mean ± SD, years | 57±14 | 47±16 | 0.08 |
| PRA I, mean ± SD, % | 15±26 | 16±26 | 0.91 |
| PRA II, mean ± SD, % | 17±29 | 12±29 | 0.66 |
|
| |||
| Induction | |||
| Basiliximab, n | 4 | 6 | 0.60 |
| rATG, n | 11 | 11 | |
| HLA mismatch (A, B, DR), mean ± SD | 4.0±1.5 | 4.6±1.3 | 0.12 |
|
| |||
| ESRD etiology, n (%) | |||
| Unknown | 7 (21.9) | 2 (6.3) | 0.04 |
| Diabetes | 3 (9.4) | 4 (12.5) | |
| FSGS | 1 (3.1) | 5 (15.6) | |
| Other – hypertension, IgA, lupus, nephronophthisis | 4 (12.5) | 6 (18.8) | |
BMI, body mass index; DGF, delayed graft function; ESRD, end-stage renal disease; FSGS, focal segmental glomerulosclerosis; PRA, panel-reactive antibody; rATG, rabbit anti-thymocyte globlulin.